Zolgensma 2 × 10 13 vector genomes/mL solution for infusion

  • DHPC
Company
Novartis Ireland Limited
Active Ingredient
Strength
  • 2
Dosage Form
Solution for infusion
Legal Category
C - restricted prescription
Last Updated
25/09/2026

Direct Healthcare Professional Communications

  • Zolgensma (onasemnogene abeparvovec) - Important Safety Information

    Direct Healthcare Professional Communication (DHPC)

    PDF228.05 KB

Novartis Ireland Limited

Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, Ireland, Dublin

Email
medinfo.dublin@novartis.com